Clinic
Shahzaib Mirza MD Medical Partners PA
Shahzaib Mirza MD Medical Partners PA was paid $91K by Medicaid between Jun 2022 and Dec 2024, across 21 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 29% of everything it billed.
33Billing provider infoSHAHZAIB MIRZA MD MEDICAL PARTNERS PA
ESTERO, FL 33928
ESTERO, FL 33928
33aNPI1649949447assigned 09/07/2021
33bProvider typePrimary Care Clinic/Center
28Total paid$91K
24GClaims3,589
24DCodes billed21
24AFirst – last monthJun 2022 – Dec 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in Florida
Rank by total paid#72 of 215
Median peer was paid$25K
This provider vs. median3.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 163 | $3K | |
| 2023 | 1,745 | $31K | |
| 2024incomplete | 1,681 | $57K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 539 | 462 | $27K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 497 | 441 | $16K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 13% | 241 | 220 | $12K |
| 87634 | 11% | 235 | 213 | $10K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 9.9% | 239 | 219 | $9K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.9% | 521 | 260 | $4K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.5% | 381 | 153 | $2K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.4% | 28 | 26 | $2K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.4% | 32 | 30 | $2K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.0% | 27 | 26 | $2K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.0% | 95 | 89 | $2K |
| 90461 | 1.1% | 176 | 142 | $985.44 |
9 more codes
| 90670 | <1% | 13 | $900.25 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 71 | $865.13 |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 51 | $708.79 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 12 | $119.04 |
| 87807 | <1% | 17 | $26.69 | |
| 99173 | 0% | 192 | $0.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 15 | $0.00 |
| 92551 | 0% | 194 | $0.00 | |
| 96127 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMIRZA, SHAHZAIB (CEO/MD)